NPI: 1023061496 · HUNTSVILLE, AL 35801 · Ambulatory Surgical Clinic/Center · NPI assigned 05/18/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR) |
| NPI Enumeration Date | 05/18/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 23,639 | $402K |
| 2019 | 22,456 | $407K |
| 2020 | 12,664 | $258K |
| 2021 | 13,512 | $262K |
| 2022 | 14,797 | $313K |
| 2023 | 17,009 | $455K |
| 2024 | 10,154 | $291K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 14,861 | 13,680 | $880K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 18,834 | 17,374 | $670K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 561 | 542 | $134K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 16,617 | 15,240 | $127K |
| 80048 | Basic metabolic panel (calcium, ionized) | 13,822 | 12,649 | $119K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 474 | 433 | $89K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,626 | 1,514 | $53K |
| 81001 | 9,705 | 8,906 | $33K | |
| 80076 | 5,628 | 5,205 | $32K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,806 | 2,334 | $27K |
| 70450 | Computed tomography, head or brain; without contrast material | 416 | 373 | $27K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 753 | 665 | $26K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,476 | 1,363 | $19K |
| 87070 | 1,663 | 1,564 | $17K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,586 | 1,454 | $14K |
| 83690 | 2,388 | 2,199 | $14K | |
| 71045 | Radiologic examination, chest; single view | 2,543 | 2,342 | $13K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,212 | 1,108 | $11K |
| 82150 | 1,762 | 1,634 | $10K | |
| 84484 | 1,260 | 985 | $10K | |
| 84703 | 1,224 | 1,128 | $7K | |
| 74022 | 407 | 389 | $7K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 41 | 41 | $6K |
| 82553 | 528 | 420 | $5K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,668 | 3,414 | $4K |
| 71046 | Radiologic examination, chest; 2 views | 535 | 499 | $4K |
| 87428 | 54 | 53 | $3K | |
| 82550 | 547 | 439 | $3K | |
| 80053 | Comprehensive metabolic panel | 202 | 187 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 40 | 37 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 46 | 38 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 127 | 115 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,094 | 1,928 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 201 | 86 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 391 | 207 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 42 | 40 | $2K |
| 0240U | 1,217 | 1,148 | $1K | |
| 83655 | 58 | 58 | $975.56 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 16 | 13 | $785.68 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 13 | 13 | $700.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 75 | 72 | $647.04 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 693 | 635 | $574.30 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,030 | 942 | $392.05 |
| 85610 | 98 | 91 | $300.04 | |
| 84443 | Thyroid stimulating hormone (TSH) | 13 | 12 | $223.08 |
| 72100 | 17 | 16 | $219.23 | |
| 83735 | 27 | 24 | $191.26 | |
| 85730 | 82 | 77 | $128.48 | |
| 59025 | Fetal non-stress test | 21 | 12 | $80.40 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 24 | 24 | $76.82 |
| 87210 | 15 | 12 | $60.50 | |
| 86592 | 20 | 15 | $54.54 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 16 | 12 | $43.04 |
| J1170 | Injection, hydromorphone, up to 4 mg | 29 | 26 | $23.77 |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 54 | 24 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 302 | 285 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 236 | 228 | $0.00 |
| 82962 | 35 | 12 | $0.00 |